Agilon Health Inc. Class Action Lawsuit Reminder
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: Globenewswire
- Class Action Notice: The Schall Law Firm reminds investors of a class action lawsuit against Agilon Health Inc. (NYSE:AGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act, concerning securities purchased between February 26, 2025, and August 4, 2025.
- False Statements Allegation: The complaint alleges that Agilon made false and misleading statements, overstating the effectiveness of its strategic actions, which resulted in significant investor losses when the truth emerged, highlighting serious issues with the company's financial transparency.
- Investor Rights Protection: Affected shareholders are encouraged to contact the Schall Law Firm before March 2, 2026, to participate in the lawsuit and seek compensation, indicating potential legal risks for the company regarding its accountability.
- Lawsuit Status: The class action has not yet been certified, meaning investors are not currently represented by an attorney, underscoring the importance of taking timely action to protect their rights.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AGL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AGL
Wall Street analysts forecast AGL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AGL is 0.98 USD with a low forecast of 0.50 USD and a high forecast of 1.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
1 Buy
7 Hold
2 Sell
Hold
Current: 0.832
Low
0.50
Averages
0.98
High
1.50
Current: 0.832
Low
0.50
Averages
0.98
High
1.50
About AGL
agilon health, inc. is a healthcare company. It enables primary care physicians (PCP) to be the agents for change in the communities they serve. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing for monthly payments to manage the total healthcare needs of its physician partners’ attributed patients (or global capitation arrangements). It focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform is holistic in supporting the rapid transition to a Total Care Model with technology, people, process and capital.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Agilon Health Inc. Class Action Lawsuit Reminder
- Class Action Notice: The Schall Law Firm reminds investors of a class action lawsuit against Agilon Health Inc. (NYSE:AGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act, concerning securities purchased between February 26, 2025, and August 4, 2025.
- False Statements Allegation: The complaint alleges that Agilon made false and misleading statements, overstating the effectiveness of its strategic actions, which resulted in significant investor losses when the truth emerged, highlighting serious issues with the company's financial transparency.
- Investor Rights Protection: Affected shareholders are encouraged to contact the Schall Law Firm before March 2, 2026, to participate in the lawsuit and seek compensation, indicating potential legal risks for the company regarding its accountability.
- Lawsuit Status: The class action has not yet been certified, meaning investors are not currently represented by an attorney, underscoring the importance of taking timely action to protect their rights.

Continue Reading
Agilon Health Investors Class Action Notice
- Class Action Notice: The Portnoy Law Firm advises investors of Agilon Health, Inc. (NYSE: AGL) about a class action for those who purchased securities between February 26, 2025, and August 4, 2025, with a deadline to file a lead plaintiff motion by March 2, 2026.
- Misleading Financial Guidance: The complaint alleges that Agilon failed to disclose significant industry headwinds that made their 2025 guidance unattainable, resulting in substantial losses for investors.
- Executive Departure Impact: On August 4, 2025, Agilon announced the resignation of CEO Steven Sell, described as a “termination without cause,” raising concerns about corporate governance and leadership stability.
- Stock Price Plunge: Following the release of disappointing financial results, Agilon's stock price plummeted over 50% to close at $0.8801 on August 5, 2025, reflecting extreme market pessimism regarding the company's future prospects.

Continue Reading





